CHAM
PVLA

Clear Harbor Asset Management’s Palvella Therapeutics PVLA Stock Holding History

Clear Harbor Asset Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-138
Closed -$13K – 387
2022
Q3 		$13K Buy
+138
New +$17.8K ﹤0.01% 356
2021
Q2 		– Sell
-1,903
Closed -$391K – 389
2021
Q1 		$391K Sell
1,903
-186
-9% -$40.7K 0.05% 227
2020
Q4 		$418K Sell
2,089
-433
-17% -$90.1K 0.06% 192
2020
Q3 		$418K Hold
2,522
– – 0.07% 179
2020
Q2 		$625K Sell
2,522
-196
-7% -$45.8K 0.12% 134
2020
Q1 		$496K Buy
2,718
+83
+3% +$20.9K 0.12% 127
2019
Q4 		$763K Buy
2,635
+395
+18% +$110K 0.13% 117
2019
Q3 		$611K Buy
2,240
+2,115
+1,692% +$819K 0.12% 123
2019
Q2 		$47K Buy
+125
New +$37.3K 0.01% 243

Other funds holding PVLA

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Clear Harbor Asset Management's PVLA Position: Q4 2022 in Review

Clear Harbor Asset Management sold out of Palvella Therapeutics (PVLA) in Q4 2022, closing a stake of 138 shares — an estimated $13K sold.

Clear Harbor Asset Management first reported a position in PVLA in Q2 2019 and held it in 9 quarters. The position peaked at $763K in Q4 2019. 63 funds tracked by Wall St. Rank hold PVLA as of Q4 2022.

  • Clear Harbor Asset Management reported no remaining Palvella Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Clear Harbor Asset Management sold 138 Palvella Therapeutics shares in Q4 2022, an estimated $13K.
  • Clear Harbor Asset Management first reported a position in Palvella Therapeutics in Q2 2019 and held it in 9 quarters.
  • Clear Harbor Asset Management's Palvella Therapeutics position peaked at $763K in Q4 2019.
  • 63 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2022.

Based on Clear Harbor Asset Management's 13F filing for Q4 2022, filed 20 Jan 2023.